Mealey's PI/Product Liability - Accutane Maker Warned Of IBD Risk; Drug Didn't Injure, Defense Tells N.J. Jurors

ATLANTIC CITY, N.J. - Hoffman-La Roche timely warned about the risk of inflammatory bowel disease (IBD) from Accutane, and the drug did not cause IBD-related injuries to a woman who took it, counsel for the company told a New Jersey state court jury on Jan. 31 in opening arguments for a retrial of the case (Kamie Kendall v. Hoffman-La Roche, No.M-165/166 September Term 2013, No. 073081, N.J. Sup., Atlantic Co.).

Access this news story on®